21 May 2013
Keywords: sanofi, nv1fgf, encouraging, ph, ii, french, drug
Article | 20 March 2006
French drug major Sanofi-Aventis has presented encouraging data from a Phase IIb trial of its angiogenesis product candidate NV1FGF, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 March 2006
20 May 2013
© 2013 thepharmaletter.com